InvestorsHub Logo
Followers 3421
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: barefootrunner post# 49170

Monday, 10/31/2011 5:33:31 PM

Monday, October 31, 2011 5:33:31 PM

Post# of 97239
EXEL..$7.73 Hearing that the FDA is not giving them a SPA for their CABO drug & Ph III study. That is a big negative for investors as it increases risk in the study. SPA's are essential now especially when looking at defining clinical endpoints in a study.

Sheff's Station...All Aboard...Sign Up Here!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.